$SMMT Management Changes:

Summit Therapeutics Inc. announced cash bonuses of $540,000 for CEO Dr. Mahkam Zanganeh and CFO Manmeet Soni for the 2024 fiscal year, along with a salary increase from $600,000 to $618,000 effective February 1, 2025; the company also reported a preliminary cash balance of approximately $412 million as of December 31, 2024.
#SMMT